T he disparity between the demand for solid organs and the current supply is a growing problem in the United States and Europe. Only 15-20% of individuals who satisfy criteria for becoming organ donors actually donate (1) . Many reasons may account for this discrepancy, such as the lack of consent (1), the absence of an experienced coordinator team able to solve logistic problems (2) , the use of strict donor criteria (3) , and suboptimal, unstandardized critical care management of potential organ donors (1) (2) (3) . The greatest discrepancy between organ supply and demand exists for lungs. Indeed, only 7-22% of multiple-organ donors are deemed suitable to become lung donors (4) due in part to the pulmonary dysfunction occurring in brain death (5, 6) , although countries such as Australia have recently reported a larger proportion of lung donors (6) .
More than 30% of the lungs theoretically suitable for donation are not actually utilized because, after brain death, they develop severe hypoxemia and abnormal chest radiographs (6) . The association between acute brain injury and subsequent pulmonary dysfunction is well recognized; severe brain injury resulting in brainstem death is characterized by the release of proinflammatory mediators in the systemic circulation (7) . Recent findings support the hypothesis that a preclinical lung injury characterized by an enhanced inflammatory re-sponse is present in potential donor lungs before transplantation, and this may predispose to an adverse clinical prognosis in lung transplant recipients (8) .
Guidelines for critical care management of potential organ donors suggest that after the diagnosis of brain death, treatment priority can be shifted from cerebral protection to a strategy aimed at preserving solid organ perfusion and function (9) . However, the ventilatory strategy recommended for potential lung donors (9) is similar to the one proposed for brain-injured patients: maintenance of arterial PO 2 of Ͼ100 mm Hg by the use of low levels of positive endexpiratory pressure (PEEP) and PaCO 2 of 30 -35 mm Hg by the use of high tidal volumes (V T ) (10) . The ventilatory strategy based on high V T and low PEEP may induce a further exacerbation of the pulmonary and systemic inflammatory response in patients with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) (11, 12) . Moreover, recent data suggest that this strategy may be harmful in "normal lungs" of patients recovering from cardiac surgery by enhancing the inflammatory response initiated by cardiopulmonary bypass (13, 14) . Like cardiopulmonary bypass, brainstem death initiates a severe systemic inflammatory response (7) , and therefore, the function of the "primarily inflamed" lungs of potential organ donors might be further impaired by the application of an injurious ventilatory strategy. Consequently, there is a theoretical basis to apply the protective ventilatory strategy recommended for ARDS patients to potential organ donors. Nevertheless, Gabbay et al. (6) recently reported an increase in the lung transplantation rate with a comprehensive ventilatory strategy that included the use of high V T . These discrepancies should be resolved by further clinical studies, but before proceeding with a randomized, controlled trial to determine the optimal ventilatory strategy for increasing lung transplantation rate, it is necessary to first define a control group representative of the standard practice (15) .
We performed a multiple-center observational study to determine the current ventilatory management implemented in potential multiple-organ donors admitted to the intensive care units (ICUs) of representative hospitals in the Piedmont Region in northwestern Italy. We tested the hypothesis that after the clinical diagnosis of brain death, ventilatory settings would remain identical and cardiovascular management would be modified to preserve solid organ perfusion and function.
MATERIALS AND METHODS

Study Sample and Data Collection.
A total of 15 ICUs in 13 hospitals responsible for managing Ͼ80% of potential organ donors in the Piedmont Region were selected to participate in the survey. They were chosen because of their involvement in the Regional Organ Procurement Organization, which provided general guidelines for ICU management but not specific clinical strategies for solid organ preservation. Regional ethics committees and review boards of all institutions approved the protocol. Informed consent was waived because the study required no deviation from routine medical practice. All patients admitted to one of these ICUs between May 1 and October 31, 2002, were included after diagnosis of brain death. Before the enrolment period, transplant coordinators at each site were given instructions on how to complete the written survey form. All forms were returned by e-mail or fax and reviewed for completeness and consistency. These forms contained the following blocks of information: Criteria for Brain-Death Diagnosis. According to Italian law, confirmation of the clinical diagnosis of brain death requires a 6-hr observation period during which assessment of cortical and brainstem function (including an apnea test) is performed at three separate times by a commission consisting of one neurologist, one intensivist not involved in patient care, and one medical examiner (18) .
Statistical Analysis. Data are presented as mean Ϯ SD. Comparisons between variables before and after the diagnosis of brain death were made using the paired Student's t-test for parametric continuous data and Fisher's exact test for categorical variables. The unpaired Student's t-test was used to compare subgroups when the subjects receiving therapy before the diagnosis of brain death were not the same who received the therapy after the diagnosis of brain death. A p value of Ͻ.05 was considered significant for each statistical test. Statistical analysis was performed using Statview software (Statview 4.51, Abacus Concepts, Berkeley, CA).
RESULTS
A total of 15 ICUs in 13 hospitals in the Piedmont Region participated in the study. All selected hospitals agreed to participate, and all completed their surveys. During the study period, data were collected on all the 34 potential adult organ donors admitted to the hospitals participating to the study. Demographic and baseline clinical data of potential donors are shown in Table 1 . Brain death was confirmed in all 34 patients, and all were referred to the Piedmont Regional Organ Procurement Organization. The patients who died of vascular accidents were older than patients who died of brain trauma (59 Ϯ 14 vs. 38 Ϯ 16 yrs, p Ͻ .05). Fifty-six percent of patients were Ͼ55 yrs of age, which is considered the standard age cutoff for lung donation (19) .
Respiratory Status. Five patients had history of smoking (Ͼ20 packs/yr), of whom two had chronic obstructive pulmonary disease. Patients were ventilated for a median of 2.7 days (range, 0.5-19 days). In 12 patients, there was suspicion of aspiration-ten met criteria for pulmonary infection, all of whom were treated with antibiotics, and no patient developed sepsis. Five patients developed ALI/ARDS.
Ventilatory Management. Before the diagnosis of brain death, patients were ventilated with an average V T of 9.7 Ϯ 1.6 mL/kg ideal body weight (range, 6.7-13.7 mL/kg ideal body weight), achieving a PaCO 2 of Ͻ35 mm Hg in 12 patients (35%) and between 35 and 45 mm Hg in 22 patients (65%). Twelve patients (35%) were ventilated with 0 cm H 2 O of PEEP, 19 patients (56%) with 1-6 cm H 2 O of PEEP, and three patients (9%) with PEEP between 7 and 8 cm H 2 O. There were no differences in ventilatory setting among patients with ARDS, pulmonary infection, and normal lungs ( Table 2) . No changes were made to the ventilator settings after the diagnosis of brain death in 33 of 34 patients (97%) ( Table 3) . For one patient, the FIO 2 was decreased from 1.0 to 0.8 after the diagnosis of brain death. The distribution of V T and PEEP levels in the 34 donors is shown in Figures 1 and 2 , respectively. Excluding patients with ALI/ ARDS, pulmonary infection/aspiration, and age of Ͼ65 yrs, there were 11 potential lung donors. In this subgroup, during the 6-hr observation period, apnea tests were performed with apneic oxygenation after disconnection from the ventilator in all cases, tracheal suction was performed with an open circuit in eight cases, and no recruitment maneuvers were performed.
Hemodynamic Management. There was a significant increase in the total fluids infused (crystalloids plus colloids) after confirmation of brain death (192 Ϯ 160 vs. 313 Ϯ 167 mL/hr, p Ͻ .05). Mean central venous pressure significantly increased during the 6-hr observation period (p Ͻ .05), and urine output tended to increase, although not significantly (Table 3). Inotropic support was used in 24 donors (70%). Cumulative fluid balance in the 48 hrs preceding the declaration of brain death was 616 mL (range, Ϫ800 to 5355 mL) and Ϫ190 (range, Ϫ2678 to 5660 mL) in patients with PaO 2 /FIO 2 ratios of Ͼ300 and Ͻ300, respectively (p ϭ not significant).
According to standard criteria for lung transplantation, at the beginning of the 6-hr brain-death assessment period, 23 potential donors were ineligible for lung donation based on pulmonary status and age. Of the 11 eligible lung donors, only two donated the lungs because five had PaO 2 /FIO 2 ratios of Ͻ300 and four were ineligible for logistic problems (Fig. 3) . Patients with PaO 2 /FIO 2 ratios of Ͻ300 were between the age of 55 and 65 yrs, died because of cerebrovascular accident in four cases and anoxic brain injury in one case, had no abnormal chest radiograph or history of lung pathology (except for one with asthma), and had plateau pressures equal to 21 Ϯ 5 cm H 2 O.
All exclusion criteria met by the 32 non-lung donors are shown in Table 4 . From the 34 potential multiple-organ donors, six hearts, 22 livers, 38 kidneys, two pancreases, and three lungs (from two donors) were procured.
DISCUSSION
Our study shows that 45% of potential lung donors had PaO 2 /FIO 2 ratios of Ͻ300, making them ineligible for lung donation, although they had normal chest radiographs and low plateau pressures. After the diagnosis of brain death, ventilatory management was not modified from a "cerebral-protective" to a "lung-protective" strategy, and no maneuvers for recruiting the lung and preventing mechanical stretch were routinely performed. Conversely, cardiovascular management was modified to optimize peripheral organ perfusion.
Although lung transplantation remains the best treatment for many pulmonary diseases, the discrepancy between organ supply and demand is a growing problem common to the United States, Europe, and other countries (1, 20) . Recently, a consensus report (9) pointed out that critical care management of potential organ donors repre-
in avoiding critical delays in donor referral and evaluation (2, 3), the increase of consent rates responsible for Ͼ50% of organ procurement exclusion, and the eligibility criteria applied to potential donor lungs (21) .
The Piedmont Region in northwestern Italy has one of the highest organ donor utilization rates across the European Union but a low lung procurement rate. In 2001, there were 39 per million population potential organ donors and 25 per million population donors utilized, but only 5.3% of potential lungs donors were procured and 4.3% transplanted, a rate similar to international reports (4). In our survey performed in the Piedmont Region, the most representative ICUs for the standard care of brain-dead patients were selected, and we reported a conversion rate from potential to actual multiple-organ donors of 71%, with a consent rate of 75%. However, of 24 multipleorgan donors utilized, only 8% were used as lung donors, and thus, only 6.2% of potential lungs were transplanted. Among the 11 potential lung donors, seven were between 55 and 65 yrs of age; expanding donor age criteria would have allowed them to be considered. The high percentage of donors with advanced age can be explained by the primary neurologic diagnosis, cerebrovascular accident, which usually occurs in older patients and was present in 70% of potential donors.
Only two potential donors were utilized for lung transplantation, and 45% of potential lung donors were excluded because of PaO 2 /FIO 2 ratios of Ͻ300, even though they had normal chest radiographs and low plateau pressures. Differences among countries have been recently reported in terms of proportion of multiple-organ donors being lung donors, ranging from 23% to 37% (22) (23) (24) . This variability may reflect real differences in intensive care management and criteria used to select lung donors. In particular, the traditional oxygenation (25) and donor age criteria are probably too conservative; in fact, acceptable outcomes with expanded donor criteria have been reported in several centers (6, 26, 27) . Severely brain-injured patients develop ALI/ARDS in 15-20% of cases, and lung function can be impaired through different mechanisms: neurogenic pulmonary edema, aspiration, hemopneumothorax, atelectasis, and later on, pneumonia (28) . The presence of pulmonary dysfunction in acute brain injury is well known; in the past, it was attributed to a hydrostatic phenomenon induced by a massive increase in sympathetic activity (29) , but an acute systemic inflammatory response seems to play an integral role in the development of such injury by initiating infiltration of activated neutrophils into the lung (30, 31) . Moreover, we have previously suggested that severe brain injury resulting in brainstem death is characterized by the release of proinflammatory mediators into the systemic circulation (7). This inflammatory response may determine a preclinical lung injury present in potential donor lungs that, together with the ischemia-reperfusion injury, may affect graft function (8) . Indeed, Follette et al. (32) reported that the administration of high-dose steroids after brain death improved oxygenation and increased lung donor utilization by limiting the cytokine-mediated cellular injury. Guidelines suggest that critical care management priority of potential organ donors should be shifted from a cerebralprotective strategy to a strategy able to preserve peripheral organ function. Recently, recommendations of the Lung Work Group (9) suggested the following ventilatory strategy: maintain adequate oxygenation (PaO 2 of Ͼ100 mm Hg) with low FIO 2 and PEEP of 5 cm H 2 O and use V T equal to 10 -12 mL/kg to maintain PaCO 2 equal to 30 -35 mm Hg (7.35-7.45 pH) and peak airway pressure of Ͻ30 mm Hg. Bronchoscopy, frequent suctioning, and aspiration precautions were also recommended, and fluid management guided by pulmonary artery catheter monitoring was desirable to ensure endorgan perfusion targeting a central ve- nous pressure of 6 -8 mm Hg and occlusion pressure of 8 -12 mm Hg. Guidelines for brain-injured patients propose a similar ventilatory strategy to protect the brain, based on the use of high V T to maintain mild hypocapnia (PaCO 2 , 30 -35 mm Hg) for treatment of intracranial hypertension and to optimize oxygenation with low levels of PEEP to preserve cerebral venous drainage (10) . This ventilatory strategy based on the use of high V T and low levels of PEEP may further exacerbate the pulmonary and systemic inflammatory response in patients with ALI/ARDS, with injurious effects on peripheral organs also (11, (33) (34) (35) . Therefore, although patients with ALI/ARDS are excluded from lung donation, their ventilatory management may be an important aspect of preserving their peripheral organ function. Although the use of low PEEP and high V T does not initiate an inflammatory response in normal lungs during general anesthesia (36), a further enhancement of the inflammatory response has been observed in lungs of patients recovering from cardiac surgery where the primary inflammatory stimulus was represented by the cardiopulmonary bypass (13, 14) . Similarly, the function of the primarily inflamed lungs of potential organ donors may be further impaired by the injurious effects of mechanical ventilation, leaving lungs unsuitable for transplantation. Further research is required to prove this hypothesis. Nevertheless, current recommendations for the ventilatory strategy of potential organ donors are similar to those for severe brain-injured patients and are potentially injurious for the lung graft, even in the absence of ARDS. Gabbay et al. (6) proposed a policy of therapeutic manipulation of marginal donors to improve gas exchange: increase V T and PEEP, bronchial toilet, physiotherapy, careful fluid resuscitation, and antibiotic therapy. After implementation of this strategy focusing on a careful policy of aspiration and treatment of atelectasis, the authors reported in 34% of marginal donors the improvement in PaO 2 /FIO 2 ratios of Ͼ300 and the increase in number of lungs suitable for transplant without adversely affecting results from transplantation. This strategy, including the increase in V T , is in contradiction with theoretical beneficial effects of the protective ventilatory strategy proposed by the ARDS Network. Consequently, there is no conclusive evidence to support the current recommendation for the management of lung donors. We performed an observational survey to identify the actual current ventilatory management adopted in potential organ donors examining the hypothesis that after diagnosis of brain death, no changes in ventilatory strategy are applied to preserve lung function and cardiovascular management is modified to preserve peripheral organ perfusion. Confirming previous reports (6), we found that 45% of potential donors were ineligible for lung donation because of a low PaO 2 /FIO 2 ratio, although these patients had normal chest radiographs and normal plateau pressures. All patients were ventilated with V T equal to 10 Ϯ 2 mL/kg ideal body weight, 91% were ventilated with PEEP between 0 and 6 cm H 2 O, and no changes were made after diagnosis of brain death. Tracheal suctioning was routinely done with an open circuit, apnea tests were never performed during the application of continuous positive airway pressure but after disconnection from the ventilator, and no recruitment maneuvers were performed at any time. Conversely, according to published guidelines (3), aggressive fluid resuscitation was implemented: fluid infusion rate was increased to guarantee peripheral organ perfusion, targeting a central venous pressure of 6 -8 mm Hg, and inotropic support was used in 70% of potential donors. The subgroup of potential lung donors with PaO 2 / FIO 2 ratios of Ͻ300 but normal plateau pressures and chest radiographs may be salvaged by the application of the protective ventilatory strategy. The use of low V T and high PEEP and the implementation of tracheal suction by a closed circuit and apnea test by continuous positive airway pressure has the theoretical presupposition of preventing hyperinflation and derecruitment of the lung, respectively. This survey was necessary to define a control group representative of the current standard practice before proceeding to a multiple-center, randomized, controlled trial testing the hypothesis that a protective ventilatory strategy is effective in increasing the number of transplantable lungs (15) . Indeed the definition of the standard care control group helps in solving ethical and methodologic problems by allowing a trial to be stopped early if the intervention has a mortality or survival rate significantly higher than current standard practice (15) . With potential organ donors, ethical concerns may be particularly relevant (37) because different strategies will be applied to two groups of subjects unable to give informed consent, being already dead, and the application of the different strategies may have an effect on a third patient population: organ recipients. The term "standard care" refers to routine ICU practice representing the treatment that physicians provide to their patients (i.e., the normative baseline to which other strategies should be compared with establish "best practice").
CONCLUSIONS
In conclusion our data show that 45% of potential lung donors had PaO 2 /FIO 2 ratios of Ͻ300, rendering them ineligible for lung donation. After the diagnosis of brain death, ventilatory management remained the same, no maneuvers for recruiting the lung and preventing mechanical stretch due to tidal recruitment or tidal hyperinflation were performed, and cardiovascular management was modified to optimize peripheral organ perfusion. These data represent the current standard of care for ventilatory management of potential organ donors and serve as the definition of a protocolized control group of an ongoing multiplecenter, randomized, controlled trial on protective ventilatory strategy in potential organ donors (information available at: http://pops.ddmc.unito.it/popsstudy). 
